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THE TERRORIST ATTACKS ON THEWorld Trade Center (WTC) onSeptember 11, 2001, claimedmore than 2700 lives and ex-
posed hundreds of thousands of people
to dust, debris, pulverized building ma-
terials, and potentially toxic emis-
sions, resulting in short- and medium-
term health effects.1-6 The dust, smoke,
and aerosols were complex mixtures of
volatile chemicals and respirable par-
ticulate matter less than 2.5 m in di-
ameter and contained known and sus-
pected carcinogens including asbestos,
silica, benzene, polychlorinated biphe-
nyls, polycyclic aromatic hydrocar-
bons, volatile organic compounds, and
numerous metals.7-10
The presence of carcinogenic agents
raises the possibility that exposure to
the WTC environment could eventu-
ally lead to cancers. Thus far, the only
systematic examination of cancer inci-
dence is a study of 9853 male firefight-
ers employed by the Fire Department
of the City of New York (FDNY).11 Zeig-
Owens et al11 reported 19% excess in-
cidence for all cancer sites combined
among WTC-exposed firefighters com-
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Context The terrorist attacks of September 11, 2001, resulted in the release of known
and suspected carcinogens into the environment. There is public concern that expo-
sures may have resulted in increased cancers.
Objective To evaluate cancer incidence among persons enrolled in the World Trade
Center Health Registry.
Design, Setting, and Participants Observational study of 55 778 New York State
residents enrolled in the World Trade Center Health Registry in 2003-2004, including
rescue/recovery workers (n=21 850) and those not involved in rescue/recovery
(n=33 928), who were followed up from enrollment through December 31, 2008.
Within-cohort comparisons using Cox proportional hazards models assessed the re-
lationship between intensity of World Trade Center exposure and selected cancers.
Main Outcome Measures Cases were identified through linkage with 11 state can-
cer registries. Standardized incidence ratios (SIRs) adjusted for age, race/ethnicity, and
sex were computed with 2003-2008 New York State rates as the reference, focusing
on cancers diagnosed in 2007-2008 as being most likely to be related to exposure
during September 11 and its aftermath. The total and site-specific incidence rate dif-
ferences (RDs) per 100 000 person-years between the study population and the New
York State population in 2007-2008 also were calculated.
Results There were 1187 incident cancers diagnosed, with an accumulated 253 269
person-years (439 cancers among rescue/recovery workers and 748 among those not
involved in rescue/recovery). The SIR for all cancer sites combined in 2007-2008 was not
significantly elevated (SIR, 1.14 [95% CI, 0.99 to 1.30]; RD, 67 [95% CI, 6 to 126] per
100 000 person-years among rescue/recovery workers vs SIR, 0.92 [95% CI, 0.83 to 1.03];
RD, 45 [95% CI, 106 to 15] per 100 000 person-years among those not involved in
rescue/recovery). Among rescue/recovery workers, the SIRs had significantly increased
by 2007-2008 for 3 cancer sites and were 1.43 (95% CI, 1.11 to 1.82) for prostate can-
cer (n=67; RD, 61 [95% CI, 20 to 91] per 100 000 person-years), 2.02 (95% CI, 1.07 to
3.45) for thyroid cancer (n=13; RD, 16 [95% CI, 2 to 23] per 100 000 person-years),
and 2.85 (95% CI, 1.15 to 5.88) for multiple myeloma (n=7; RD, 11 [95% CI, 2 to 14]
per 100 000 person-years). No increased incidence was observed in 2007-2008 among
those not involved in rescue/recovery. Using within-cohort comparisons, the intensity of
World Trade Center exposure was not significantly associated with cancer of the lung,
prostate, thyroid, non-Hodgkin lymphoma, or hematological cancer in either group.
Conclusions Among persons enrolled in the World Trade Center Health Registry,
there was an excess risk for prostate cancer, thyroid cancer, and myeloma in 2007-
2008 compared with that for New York State residents; however, these findings were
based on a small number of events and multiple comparisons. No significant associa-
tions were observed with intensity of World Trade Center exposures. Longer follow-up
for typically long-latency cancers and attention to specific cancer sites are needed.
JAMA. 2012;308(23):2479-2488 www.jama.com
©2012 American Medical Association. All rights reserved. JAMA, December 19, 2012—Vol 308, No. 23 2479
Downloaded From: http://jama.jamanetwork.com/ by a Columbia University User  on 12/18/2012
pared with unexposed firefighters in the
7 years following September 11. Most
of the excess incidence was composed
of prostate and thyroid cancers, non-
Hodgkin lymphoma, and melanoma. A
mortality study from the WTC Health
Registry, in which 41 930 WTC-
exposed New York City residents were
followed up through 2009, found that
the total mortality from potentially
short incubation and fatal hematologi-
cal malignancies did not differ signifi-
cantly from expected.12 However, the
follow-up period was short relative to
the onset and survival times for most
cancers.
We evaluated cancer incidence to de-
termine any excess cancer among res-
cue/recovery workers and volunteers
and those not involved in rescue/
recovery enrolled in the registry, lay-




The World Trade Center Health Reg-
istry is a cohort study designed to
monitor the health effects of the
September 11 attacks among rescue/
recovery workers and persons who
lived, worked, or attended school in
lower Manhattan. The study methods
have been published elsewhere.2,13
Briefly, in 2003-2004 a total of
71 434 persons completed a tele-
phone (95%) or in-person (5%)
interview. Participants were either
identified through lists provided by
employers, government agencies, and
other entities (30%; list identified) or
they responded to an outreach cam-
paign (70%; self-identified). Cover-
age of the eligible population was
estimated as 34% for rescue/recovery
workers and 23% for residents.14 Ver-
bal informed consent was obtained
from each of the participants. This
analysis included registry enrollees
who were New York State (NYS)
residents on September 11 and at
risk for a first primary invasive can-
cer at the time of registry enrollment,
defined as never having had a pri-
mary invasive cancer documented in
any of the 11 state cancer registries
we used for case identification.
This study was approved by the in-
stitutional review board of the New
York City Department of Health and
Mental Hygiene. Each cancer registry
record linkage was also approved by the
respective institutional review board of
10 state departments of health listed be-
low and the University of Medicine and
Dentistry of New Jersey.
Outcome Definition
Cancers were identified through rec-
ord linkage with 11 state cancer regis-
tries. Eligible study participants were
matched to cancer registries that have
been population based since 1976 (in
NYS) and 1978 (in New Jersey). Resi-
dents of NYS on September 11 who
later moved to California, Connecti-
cut, Florida, North Carolina, Massa-
chusetts, Ohio, Pennsylvania, Texas,
or Washington were matched to the
corresponding state cancer registry.
The proportion of the cancer cases
with a full or partial social security
number was similar to that in noncan-
cer cases (76.1% vs 76.5%, respec-
tively; P = .78). An incident cancer
case is defined as a first primary inva-
sive cancer or in situ bladder cancer
matched to a state cancer registry and
diagnosed any time postenrollment
through December 31, 2008, the last
date for which complete cancer inci-
dence records were available for
observed and expected cancer compu-
tations. Cancer site was defined using
the Surveillance, Epidemiology, and
End Results (SEER) site recode Inter-
national Classification of Diseases for
Oncology, Third Edition, grouping, in
which categories are based on primary
site and histology.15
Exposure to WTC and Covariates
Demographic and exposure data were
obtained at registry enrollment.
Rescue/recovery workers were first
responders, volunteers, and others
who worked at the WTC site, debris-
loading sites, on barges, or at the
Staten Island landfill between Septem-
ber 11, 2001, and June 30, 2002. Par-
ticipants not involved in rescue/
recovery were residents, children, and
staff in schools (prekindergarten-12th
grade) south of Canal Street and area
workers and passersby south of
Chambers Street on September 11 in
lower Manhattan. Persons belonging
to both groups were categorized as
rescue/recovery workers.
Separate qualitative descriptions of
WTC exposures were used to classify
exposure as high, intermediate, or low
for rescue/recovery workers (exclud-
ing those who worked exclusively on
Staten Island) and for participants not
involved in rescue/recovery (expo-
sure level definitions appear in the
eTable at http://www.jama.org). Highly
exposed rescue/recovery workers were
in the immediate area at the time of the
WTC towers’ collapse and worked on
the dust and debris pile on September
11 or worked at the site for more than
90 days starting in the first week after
September 11. Highly exposed partici-
pants not involved in rescue/recovery
reported 2 or more injuries on Septem-
ber 11, and resided or worked in lower
Manhattan and did not evacuate or were
present at school on September 11.12
Rescue/recovery workers and those not
involved in rescue/recovery generally
experienced qualitatively different ex-
posures, and were therefore analyzed
separately. Covariates included age at
enrollment, sex, race/ethnicity, 2002
household income level, education
level, smoking status, enrollment source
(list identified or self-identified), and
history of asthma, cardiovascular dis-
ease, stroke, emphysema, or diabetes re-
ported at enrollment.
Data Analyses
We compared the cancer experience of
each group with the NYS population
using the standardized incidence ratio
(SIR), computed as the ratio of ob-
served to expected cancer cases, strati-
fied by age (5-year age groups), race/
ethnicity, sex, and calendar period
(2003-2006 and 2007-2008). We used
NYS cancer rates to determine ex-
pected cases because the study popu-
lation was only NYS residents on
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September 11 and the NYS cancer reg-
istry was the source of all but 5% of
study cases.
We constructed our analysis to in-
crease the likelihood of detecting Sep-
tember 11 exposure–related cancer at
this early stage of follow-up. A little
more than 7 years elapsed between Sep-
tember 11 and the end of follow-up,
which is less than the average latency
period for most solid tumors. Never-
theless, short latency periods have been
reported for cancers associated with ex-
posure to chemicals in adults16 and ex-
posure to radiation in children.17 We
hypothesized that any exposure-
related cancers would be more likely to
emerge at least 5 years after Septem-
ber 11 and thus divided the follow-up
interval into early (enrollment through
2006) and later (2007-2008) periods,
and focused on cancers occurring in the
later period.
We computed SIRs separately for the
rescue/recovery workers and partici-
pants not involved in rescue/recovery,
after excluding 1820 enrollees (61 can-
cers) with unknown ethnicity or un-
classifiable race. Person-time of obser-
vation for each participant was
calculated from the date of enrollment
until the first cancer diagnosis, death,
or December 31, 2008, whichever came
first. The 95% confidence intervals of
the SIRs were calculated using Byar ap-
proximation to the exact Poisson
distribution.18
We also computed the rate differ-
ences (RDs) and 95% confidence in-
tervals for the later period as the dif-
ference between the actual incidence
rate per 100 000 person-years of the
study population and the incidence rate
in the NYS general population, ad-
justed by age, sex, race/ethnicity, and
calendar-year time to the distribution
of person-years in our study popula-
tion. The statistical significance and
95% confidence intervals for the RDs
were computed based on the assump-
tion of a Poisson distribution. We did
not adjust the P values for multiple
comparisons.
Cancer sites with significantly el-
evated SIRs in the later period were se-
lected for within-cohort comparisons
during the entire follow-up period and
were examined by exposure category
using Cox proportional hazards mod-
els separately for rescue/recovery work-
ers and participants not involved in res-
cue/recovery. Hematological cancers,
which include myeloma, leukemia, and
lymphoma, also were examined using
the Cox model because each has a po-
tentially shorter latency period com-
pared with solid tumors and thus might
be more likely to show an early in-
crease. Additionally, lung cancer was
included because the dust and debris
from the WTC site contained silica, as-
bestos, and other carcinogens that have
been associated with lung cancer. No
violation of the proportional hazards as-
sumption was observed for any model.
Hazard ratios (HRs) and 95% confi-
dence intervals were adjusted for age
at enrollment, sex, race/ethnicity, smok-
ing status, education level, income level,
and history of a serious, nonmalig-
nant medical condition as described
above. Source of enrollment (self-
identified vs list identified) was in-
cluded in multivariate analyses to con-
trol for potential selection bias.
To account for a 5-year lag time from
first WTC exposure, we reran the Cox
models under the assumption that can-
cers diagnosed in the early period were
unlikely to be caused by WTC expo-
sures, thereby treating all study par-
ticipants in the early period as if they
were not exposed while retaining the
originally assigned WTC exposure cat-
egory in the later period.
Because we did not have data on the
cancer screening practices of the par-
ticipants, we indirectly assessed poten-
tial screening bias in 2 ways. First, we
compared the number of stage I can-
cers for selected sites as a proportion
of total cancer diagnoses in the study
population with the corresponding
proportion in the NYS population dur-
ing the same period based on the
assumption that screening-detected
cancers are more likely to be early-
stage cancers. Second, we compared
the proportions of participants who
reported a routine physical checkup
within the preceding 12 months
between those with and without sub-
sequent cancers among all follow-up
participants. Proportions were com-
pared using the Pearson 2 test.
Descriptive and multivariate analy-
ses were performed using SAS soft-
ware version 9.2 (SAS Institute Inc), and
SIRs were computed using SEER*Stat
MP-SIR sessions software version 7.0.5
(http://www.seer.cancer.gov/seer-
stat). Significance was set at a 2-sided
P value of less than .05.
RESULTS
This analysis was restricted to the
55 778 enrollees who were NYS resi-
dents on September 11 (78% of all reg-
istry enrollees) and at risk for a first pri-
mary invasive cancer at enrollment
(FIGURE). We excluded enrollees with
preenrollment invasive cancers
(n=1473), those with unknown age or
sex (n=141), and those who died be-
fore the start of follow-up (n=148) or
withdrew with an undocumented date
(n=212). Of the 55 778 enrollees, 90%
remained in NYS throughout the fol-
low-up period, 8% moved to states cov-
ered by the 10 state cancer registries
mentioned earlier, and 2% moved else-
where.
Figure. Selection of Study Population
71 434 Participants enrolled in World
Trade Center Health Registry
cohort from 2003 to 2004
55 778 Eligible New York State
 residents for data analysis
33 928 Not involved in rescue
or recovery
21 850 Involved in rescue or
recoverya
15 656 Excluded
13 682 Not New York
State residents on
September 11, 2001




148 Died before start of
follow-up
141 Unknown age or sex
aOf the 21 850 rescue/recovery workers, there were
21 371 who worked at the World Trade Center site
and 479 who worked exclusively at the Staten Island
recovery operation landfill or on transportation barges.
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Through December 31, 2008, 1187
incident cancers were reported among
the 55 778 eligible enrollees, with an ac-
cumulated 253 269 person-years. Of
these 1187 cancers, 439 (37%) were di-
agnosed among rescue/recovery work-
ers and 748 (63%) were among partici-
pants not involved in rescue/recovery.
The median age at diagnosis across all
cancer sites was 57 years (range, 22-
103 years); none was diagnosed in per-
sons younger than 20 years old. Char-
acteristics of cancer cases and those
without cancer are shown in TABLE 1
for rescue/recovery workers and in
TABLE 2 for participants not involved
in rescue/recovery. Participants diag-
nosed with cancer in both groups were
significantly older, less likely to be His-
panic, and more likely to be ever smok-
ers, and to have a prior history of medi-
cal conditions. The proportion who
reported having a routine physical
checkup within the preceding 12
months among those with subsequent
cancer was not different from the pro-
portion among those not diagnosed




We excluded from the SIR analysis 632
rescue/recovery workers with un-
known race/ethnicity, of whom 18 were
cases. This left 421 cases for the SIR
analysis. There were 198 cancers (47%)
occurring in the early period and 223
(53%) in the later period. For all sites
combined, cancer incidence was not sig-
nificantly different from that in the ref-
erence population during either the
early period (SIR, 0.94; 95% CI, 0.82
to 1.08) or the later period (SIR, 1.14;
95% CI, 0.99 to 1.30) (RD, 67 [95% CI,
5.5 to 126.2] per 100 000 person-
years; TABLE 3).
Of the 23 cancer sites investigated,
3 had significantly elevated incidence
during the later period: prostate (n=67;
SIR, 1.43 [95% CI, 1.11-1.82]; RD, 61
[95% CI, 20.1-91.4] per 100 000 per-
son-years), thyroid (n=13; SIR, 2.02
[95% CI, 1.07-3.45]; RD, 16 [95% CI,
2.1-22.6] per 100 000 person-years),
and multiple myeloma (n=7; SIR, 2.85
[95% CI, 1.15-5.88]; RD, 11.1 [95% CI,
2.2-14.2] per 100 000 person-years). Of
these 3, thyroid cancer also was sig-
nificantly elevated during the early pe-
riod (n=14; SIR, 2.22 [95% CI, 1.22-
3.73]). Ovarian cancer was significantly
elevated during the early period (n5;
Table 1. Characteristics of Rescue/Recovery Workers With and Without First Primary
Incident Cancer During the Follow-up Period (n = 21 850)
No. (%) of Rescue/Recovery Workers
by First Primary Cancer Diagnosis






(n = 21 411)
Source of enrollment
List identified 147 (33.5) 6495 (30.3)
.16
Self-identified 292 (66.5) 14 916 (69.7)
Age at enrollment, y
20 0 69 (0.3)
20-34 20 (4.6) 4670 (21.8)
35-44 73 (16.6) 8406 (39.3) .001
45-64 313 (71.3) 7977 (37.3)
65 33 (7.5) 289 (1.4)
Sex
Male 366 (83.4) 17 299 (80.8)
.18
Female 73 (16.6) 4112 (19.2)
Race/ethnicity
Non-Hispanic white 308 (70.2) 14 218 (66.4)
Non-Hispanic black 55 (12.5) 2353 (11.0)
Hispanic 43 (9.8) 3463 (16.2)
.001
Asian 7 (1.6) 630 (2.9)
American Indian or Alaska Native 8 (1.8) 133 (0.6)
Unknown 18 (4.1) 614 (2.9)
Education at enrollment
High school 38 (8.7) 1260 (5.9)
High school 122 (27.8) 5454 (25.5)
Some college 112 (25.5) 6729 (31.4) .02
College degree 160 (36.4) 7682 (35.9)
Unknown 7 (1.6) 286 (1.3)
Household income in 2002, $
50 000 87 (19.8) 5137 (24.0)
50 000-150 000 274 (62.4) 13 183 (61.6)
.09
150 000 33 (7.5) 1249 (5.8)
Unknown 45 (10.3) 1842 (8.6)
Smoking status at enrollment
Current 70 (15.9) 4010 (18.7)
Former 156 (35.7) 5559 (26.0)
.001
Never 207 (47.0) 11 603 (54.2)
Unknown 6 (1.4) 239 (1.1)
Preexisting medical conditiona
Yes 163 (37.1) 4467 (20.9)
.001
No or unknown 276 (62.9) 16 944 (79.1)
World Trade Center exposure levelb
Low 26 (5.9) 1456 (6.8)
Intermediate 330 (75.2) 16 382 (76.5)
High 58 (13.2) 2884 (13.5) .04
Missing or unknown 6 (1.4) 229 (1.1)
Worked exclusively at Staten
Island site
19 (4.3) 460 (2.2)
a Included asthma, cardiovascular disease, stroke, emphysema, or diabetes reported at enrollment.
bExposure level definitions appear in the eTable at http://www.jama.com.
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SIR, 3.32 [95% CI, 1.08-7.74]) but not
during the later period (no cases re-
ported). Nonsignificant SIRs exceed-
ing 2.0 were observed for Hodgkin lym-
phoma in both periods based on 5 cases
or less in each period.
Firefighters enrolled in the registry
may have been included in the study
by Zeig-Owens et al.11 We recalcu-
lated later period SIRs excluding 2965
(2888 males and 77 females) FDNY fire-
fighters in the registry to address the
possibility that annual cancer screen-
ing of firefighters might lead to earlier
cancer diagnoses. After exclusion, the
later period SIR for thyroid cancer de-
creased and became nonsignificant
(n = 10; SIR, 1.76 [95% CI, 0.85-
3.24]), whereas the SIRs for prostate
cancer (n=54; SIR, 1.35 [95% CI, 1.01-
1.76]) and multiple myeloma (n=6;
SIR, 2.79 [95% CI, 1.02-6.06]) re-
mained significantly elevated.
A significantly reduced SIR was ob-
served for lung cancer during the early
period based on 11 observed cases (SIR,
0.49 [95% CI, 0.24 to 0.87]). The later
period SIR for lung cancer was re-
duced but was not statistically signifi-
cant (n=13; SIR, 0.65 [95% CI, 0.35 to
1.12]; RD, 17.2 [95% CI, 59.2 to
3.4] per 100 000 person-years). No me-
sothelioma cases were reported. Breast
cancer among female rescue/recovery
workers was significantly reduced dur-
ing the early period (n=6; SIR, 0.40
[95% CI, 0.15 to 0.87]), but not dur-




We excluded from the SIR analysis 1188
participants not involved in rescue/
recovery with unkown race/ethnicity,
of whom 43 were cases. This left 705
cases for the SIR analysis. There were
381 cancers (54%) in the early and 324
(46%) in the later period (TABLE 4). For
all cancer sites combined, cancer inci-
dence was not significantly different
from the reference population during
either the early (SIR, 0.92 [95% CI,
0.83 to 1.02]) or later period (SIR,
0.92 [95% CI, 0.83 to 1.03]; RD, 45.0
[95% CI, 106.1 to 15.1] per 100 000
person-years).
In the early period, the SIR for Hodg-
kin lymphoma was significantly higher
than expected (n=8; SIR, 2.60 [95% CI,
1.12 to 5.13]) and colorectal cancer was
significantly lower than expected
(n = 25; SIR, 0.64 [95% CI, 0.42 to
0.95]). Both cancers were nonsignifi-
cant in the later period with the SIR for
Table 2. Characteristics of Participants Not Involved in Rescue/Recovery With and Without
First Primary Incident Cancer During the Follow-up Period (n = 33 928)
No. (%) of Participants
Not Involved in Rescue/Recovery







(n = 33 180)
Source of enrollment
List identified 198 (26.5) 7833 (23.6)
.07
Self-identified 550 (73.5) 25 347 (76.4)
Age at enrollment, y
20 0 2954 (8.9)
20-34 28 (3.7) 7743 (23.3)
35-44 84 (11.2) 8025 (24.2) .001
45-64 475 (63.5) 12 571 (37.9)
65 161 (21.5) 1887 (5.7)
Sex
Male 336 (44.9) 14 670 (44.2)
.70
Female 412 (55.1) 18 510 (55.8)
Race/ethnicity
Non-Hispanic white 441 (59.0) 17 927 (54.0)
Non-Hispanic black 118 (15.8) 5153 (15.5)
Hispanic 66 (8.8) 4734 (14.3)
.001
Asian 77 (10.3) 4102 (12.4)
American Indian or Alaska Native 3 (0.4) 119 (0.4)
Unknown 43 (5.8) 1145 (3.5)
Education at enrollment
High school 67 (9.0) 4274 (12.9)
High school 124 (16.6) 4777 (14.4)
Some college 158 (21.1) 6143 (18.5)
.002
College 381 (50.9) 17 460 (52.6)
Unknown 18 (2.4) 526 (1.6)
Household income in 2002, $
50 000 256 (34.2) 12 026 (36.2)
50 000-150 000 291 (38.9) 12 553 (37.8)
.02
150 000 78 (10.4) 4238 (12.8)
Unknown 123 (16.4) 4363 (13.1)
Smoking status at enrollment
Current 120 (16.0) 4788 (14.4)
Former 275 (36.8) 7683 (23.2)
.001
Never 337 (45.1) 18 729 (56.4)
Unknown 16 (2.1) 1980 (6.0)
Preexisting medical conditiona
Yes 335 (44.8) 8013 (24.2)
No or unknown 413 (55.2) 25 167 (75.8)
.001
World Trade Center exposure levelb
Low 347 (46.4) 16 054 (48.4)
Intermediate 326 (43.6) 14 220 (42.9)
.06
High 57 (7.6) 2476 (7.5)
Missing or unknown 18 (2.4) 430 (1.3)
a Included asthma, cardiovascular disease, stroke, emphysema, or diabetes reported at enrollment.
bExposure level definitions appear in the eTable at http://www.jama.com.
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Hodgkin lymphoma dropping below 1
(n5; SIR, 0.48 [95% CI, 0.01 to 2.66];
RD, 1.7 [95% CI, 158.3 to 1.0] per
100 000 person-years). There were
fewer observed lung cancer cases than
expected during both periods.
Proportional Hazards Analyses
TABLE 5 shows the adjusted HRs
(AHRs) by exposure level for selected
cancers during the entire follow-up
period. Multivariate analyses were not
performed separately for myeloma,
Hodgkin lymphoma, or leukemias
due to very small numbers of cases.
The exposure metric was not signifi-
cantly associated with any individual
cancer site for either group. For
hematological cancers among rescue/
recovery workers, the intermediate
exposure AHR was 3.7, and the high
exposure AHR was 4.5 compared with
the low exposure level; however, nei-
ther the trend nor either AHR was sig-
nificant (P= .20 for trend). When a
5-year lag time was introduced, the
AHRs for hematological cancer were
lower for both intermediate (AHR, 1.6
[95% CI, 0.8-3.0]) and high exposure
(AHR, 1.5 [95% CI, 0.5-4.5]). All of
the 95% confidence intervals in
Table 5 included unity and were thus
not statistically significant.
Table 3. Standardized Incidence Ratio (SIR) Adjusted for Age, Race/Ethnicity, and Sex and 2007-2008 Rate Difference of First Primary Cancer




(n = 21 218)a
Later Period
(2007-2008)









Observedc SIR (95% CI)d
No.






All first primary invasive
malignant tumors
198 0.94 (0.82 to 1.08) 223 1.14 (0.99 to 1.30) 546.7 479.6 67.1 (5.5 to 126.2)
Oral cavity and pharynx 8 1.13 (0.49 to 2.24) 5 0.77 (0.25 to 1.80) 12.3 15.9 3.7 (36.8 to 5.4)
Esophagus 5 1.43 (0.39 to 3.67) 5 1.16 (0.24 to 3.39) 7.4 6.3 1.0 (23.3 to 5.2)
Stomach 5 0.52 (0.06 to 1.88) 5 0.91 (0.19 to 2.67) 7.4 8.1 0.7 (31.4 to 4.6)
Colorectal 15 0.80 (0.45 to 1.31) 21 1.24 (0.77 to 1.90) 51.5 41.5 10.0 (15.4 to 24.4)
Liver and intrahepatic
bile duct
5 0.43 (0.05 to 1.54) 6 1.22 (0.45 to 2.67) 14.7 12.1 2.7 (18.0 to 9.2)
Pancreas 6 1.37 (0.50 to 2.97) 5 0.70 (0.14 to 2.03) 7.4 10.5 3.2 (45.2 to 3.7)
Larynx 5 1.76 (0.57 to 4.11) 0 0 (0 to 1.52)
Lung and bronchus 11 0.49 (0.24 to 0.87) 13 0.65 (0.35 to 1.12) 31.9 49.0 17.2 (59.2 to 3.4)
Melanoma of the skin 14 1.61 (0.88 to 2.70) 10 1.32 (0.63 to 2.43) 24.5 18.6 5.9 (14.4 to 14.4)
Female breast 6 0.40 (0.15 to 0.87) 18 1.39 (0.82 to 2.20) 231.9 166.9 65.1 (50.9 to 126.5)
Cervix uteri 0 0 (0 to 2.67) 0 0 (0 to 3.45)
Corpus uterus and not
otherwise specified
5 0.97 (0.20 to 2.83) 0 0 (0 to 1.27)
Ovary 5 3.32 (1.08 to 7.74) 0 0 (0 to 3.04)
Prostate 48 1.12 (0.83 to 1.49) 67 1.43 (1.11 to 1.82) 202.8 141.9 61.0 (20.1 to 91.4)
Testis 5 0.75 (0.15 to 2.18) 5 0.36 (0.01 to 1.98) 3.0 8.4 5.4 (299.7 to 1.5)
Urinary bladder 9 0.96 (0.44 to 1.83) 8 0.94 (0.41 to 1.85) 19.6 20.9 1.3 (28.2 to 9.0)
Kidney and renal pelvis 6 0.68 (0.25 to 1.48) 12 1.38 (0.71 to 2.41) 29.4 21.3 8.1 (12.0 to 17.2)
Brain and other
nervous system
5 1.02 (0.28 to 2.62) 5 0.68 (0.08 to 2.45) 4.9 7.2 2.3 (56.4 to 2.9)
Thyroid 14 2.22 (1.22 to 3.73) 13 2.02 (1.07 to 3.45) 31.9 15.8 16.1 (2.1 to 22.6)
Hodgkin lymphoma 5 2.08 (0.68 to 4.86) 5 2.47 (0.67 to 6.31) 9.8 4.0 5.8 (4.8 to 8.3)
Non-Hodgkin lymphoma 12 1.10 (0.57 to 1.92) 11 1.15 (0.57 to 2.06) 27.0 23.4 3.5 (20.3 to 13.9)
Multiple myeloma 5 0.38 (0.01 to 2.11) 7 2.85 (1.15 to 5.88) 17.2 6.0 11.1 (2.2 to 14.2)
Leukemia 5 0.73 (0.20 to 1.87) 6 1.25 (0.46 to 2.72) 14.7 11.8 2.9 (17.3 to 9.3)
Abbreviations: NYS, New York State; RD, rate difference.
aAnalysis limited to the 21 218 rescue/recovery workers with known race/ethnicity.
bBy the late period, of the 21 218 rescue/recovery workers with known race/ethnicity, 227 had been either diagnosed with cancer or died during the early period, and were therefore not
eligible for inclusion in the late period analysis.
cDefined as the first primary cancers that were diagnosed between enrollment and December 31, 2006. All observed cancer cases were documented in the NYS cancer registry (n=192)
and other state cancer registries (Florida=4, New Jersey=1, and Pennsylvania=1). Exact numbers not provided to comply with internal New York City Department of Health and Mental
Hygiene and New York State cancer registry policies of not reporting small numbers.
dExpected cancers are based on 2003-2006 NYS incidence rates for the early period and 2007-2008 rates for the later period.
eDefined as the first primary cancers that were diagnosed between January 1, 2007, and December 31, 2008. All observed cancer cases were documented in the NYS cancer registry
(n=209) and other state cancer registries (California=2, Connecticut=1, Florida=6, North Carolina=1, New Jersey=1, and Pennsylvania=3). Exact numbers not provided to comply
with internal New York City Department of Health and Mental Hygiene and New York State cancer registry policies of not reporting small numbers.
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COMMENT
Dust, debris, and fumes from the
WTC contained known and sus-
pected carcinogens, including polycy-
clic aromatic hydrocarbons, asbestos,
benzene, and dioxins.10,19-21 At issue is
whether dosages to exposed individu-
als were sufficient to cause excess ma-
lignancies and, if so, whether such ex-
cesses are epidemiologically detectable
at present. Also at issue is whether
any specific cancer site with an ob-
served excess might plausibly be re-
lated to September 11 exposure. In
this early study with less than 8 years
of follow-up, there was no statistically
significant increased incidence for
all cancer sites combined. Among
rescue/recovery workers, however, mul-
tiple myeloma and prostate and thy-
roid cancers were significantly el-
evated in the later period. None of
the cancers chosen for within-cohort
comparisons (including the 3 with
elevated SIRs) was associated with
intensity of WTC exposure. The
increase in hematological cancers with
increasing exposure in rescue/
recovery workers was not statistically
significant.
Table 4. Standardized Incidence Ratio (SIR) Adjusted for Age, Race/Ethnicity, and Sex and 2007-2008 Rate Difference of First Primary Cancer
Site Among Participants Not Involved in the Rescue/Recovery With Known Race/Ethnicity Using New York State Population Rate as Reference




(n = 32 740)a
Later Period
(2007-2008)









Observedc SIR (95% CI)d
No.







All first primary invasive
malignant tumors
381 0.92 (0.83 to 1.02) 324 0.92 (0.83 to 1.03) 518.0 563.1 45.0 (106.1 to 15.1)
Oral cavity and pharynx 10 1.03 (0.49 to 1.89) 6 0.73 (0.27 to 1.60) 9.6 13.1 3.5 (25.9 to 3.6)
Esophagus 5 0.24 (0.01 to 1.36) 5 0.29 (0.01 to 1.59) 1.6 5.5 3.9 (158.3 to 0.6)
Stomach 5 0.49 (0.13 to 1.25) 5 0.31 (0.04 to 1.11) 3.2 10.3 7.1 (76.7 to 0.3)
Colorectal 25 0.64 (0.42 to 0.95) 23 0.75 (0.47 to 1.12) 36.8 49.0 12.3 (41.5 to 3.9)
Liver and intrahepatic
bile duct
5 0.67 (0.22 to 1.57) 9 1.30 (0.59 to 2.47) 14.4 11.1 3.3 (10.0 to 8.6)
Pancreas 9 0.99 (0.45 to 1.88) 8 0.99 (0.43 to 1.96) 12.8 12.9 0.1 (17.0 to 6.3)
Larynx 5 1.37 (0.45 to 3.20) 0 0 (0 to 1.25)
Lung and bronchus 35 0.74 (0.52 to 1.03) 26 0.66 (0.43 to 0.95) 41.6 63.0 21.4 (55.1 to 2.2)
Melanoma of the skin 18 1.48 (0.88 to 2.35) 8 0.78 (0.33 to 1.53) 12.8 16.4 3.6 (24.8 to 4.4)
Female breast 84 1.19 (0.95 to 1.48) 69 1.20 (0.93 to 1.52) 197.9 164.9 33.0 (14.9 to 67.7)
Cervix uteri 5 0.32 (0.04 to 1.16) 5 0.86 (0.23 to 2.21) 11.5 13.3 1.9 (38.4 to 6.3)
Corpus uterus and not
otherwise specified
16 1.01 (0.58 to 1.65) 14 1.01 (0.55 to 1.69) 40.1 39.7 0.4 (32.8 to 16.4)
Ovary 5 0.68 (0.22 to 1.60) 5 0.53 (0.11 to 1.56) 8.6 16.2 7.6 (69.6 to 3.1)
Prostate 65 1.18 (0.91 to 1.51) 56 1.07 (0.81 to 1.39) 202.4 189.1 13.2 (47.5 to 56.8)
Testis 5 0.73 (0.09 to 2.63) 5 1.03 (0.12 to 3.70) 7.2 7.0 0.2 (53.0 to 5.3)
Urinary bladder 11 0.71 (0.35 to 1.26) 10 0.76 (0.36 to 1.40) 16.0 21.0 5.0 (28.4 to 4.6)
Kidney and renal pelvis 11 0.86 (0.43 to 1.53) 11 0.95 (0.48 to 1.71) 17.6 18.5 0.9 (19.1 to 7.3)
Brain and other
nervous system
7 1.23 (0.50 to 2.54) 5 0.96 (0.26 to 2.45) 6.4 6.7 0.3 (18.2 to 3.8)
Thyroid 16 1.15 (0.66 to 1.86) 16 1.15 (0.66 to 1.87) 25.6 22.2 3.3 (13.2 to 11.9)
Hodgkin lymphoma 8 2.60 (1.12 to 5.13) 5 0.48 (0.01 to 2.66) 1.6 3.3 1.7 (158.3 to 1.0)
Non-Hodgkin lymphoma 13 0.76 (0.40 to 1.29) 20 1.40 (0.86 to 2.16) 32.0 22.8 9.1 (5.2 to 17.2)
Multiple myeloma 5 0.76 (0.21 to 1.95) 5 1.09 (0.35 to 2.55) 8.0 7.3 0.7 (14.8 to 4.9)
Leukemia 8 0.86 (0.37 to 1.69) 8 1.06 (0.46 to 2.09) 12.8 12.1 0.7 (15.0 to 6.7)
Abbreviations: NYS, New York State; RD, rate difference.
aAnalysis limited to the 32 740 participants not involved in rescue/recovery with known race/ethnicity.
bBy the late period, of the 32 740 participants not involved in rescue/recovery with known race/ethnicity, 524 had been either diagnosed with cancer or died during the early period, and
were therefore not eligible for inclusion in the late period analysis.
cDefined as the first primary cancers that were diagnosed between enrollment and December 31, 2006. All observed cancer cases were documented in the NYS cancer registry (n=366)
and other state cancer registries (Connecticut=2, Florida=5, Massachusetts=2, New Jersey=3, and Pennsylvania=3). Exact numbers not provided to comply with internal New York
City Department of Health and Mental Hygiene and New York State cancer registry policies of not reporting small numbers.
dExpected cancers are based on 2003-2006 NYS incidence rates for the early period and 2007-2008 rates for the later period.
eDefined as the first primary cancers that were diagnosed between January 1, 2007, and December 31, 2008. All observed cancer cases were documented in NYS cancer registry
(n=308), and other state cancer registries (California=4, Connecticut=1, Florida=6, North Carolina=1, New Jersey=3, and Pennsylvania=1). Exact numbers not provided to comply
with internal New York City Department of Health and Mental Hygiene and New York State cancer registry policies of not reporting small numbers.
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Significant excess risks for prostate
and thyroid cancers were observed.
Both cancers are frequently detected
during routine screening examina-
tions,22,23 and are potentially subject
to surveillance bias. To address this
bias, we compared the proportion
having a routine physical checkup
within the preceding 12 months
between those with and without sub-
sequent cancer. The proportions were
nearly identical. Furthermore, the
respective proportions of prostate and
thyroid cancer that were stage I at
diagnosis (85% and 66%) were similar
to those of the NYS population.24
These observations suggest that can-
cer cases in this study may not have
received more thorough cancer
screening than the NYS population in
general, although they do not elimi-
nate the possible role of surveillance
bias altogether. Also, our findings
might be prone to type I error given
the large number of comparisons.
The etiologies of thyroid and pros-
tate cancers are quite different. Thy-
roid cancer can be caused by ionizing
radiation,25 but potentially carcino-
genic levels of radiation were neither
documented nor suspected at the WTC
site. Many occupational and environ-
mental causes of prostate cancer have
been suggested but studies have been
largely inconsistent or inconclusive.26
Hematological cancers are of special in-
terest because they are generally re-
garded as having shorter latency peri-
ods than solid tumors27 and are
associated with radiation and certain
chemicals,28 and therefore could be
early indicators of cancer risk. We ob-
served 7 later period cases of multiple
myeloma among rescue/recovery work-
ers, yielding a significantly elevated SIR
of 2.85. The age distribution of these
7 cases was consistent with that of the
general population, in contrast to the
much younger age distribution in a case
series report.29
In the study by Zeig-Owens et al11 of
an FDNY cohort, the SIR was based on
fewer than 5 cases of multiple my-
eloma and was not statistically signifi-
cant. Multiple myeloma has been as-
sociated with a variety of occupations,
including fire fighting,30 painting, farm-
ing and other agricultural work,31,32 as
well as with exposure to benzene.16
However, few specific environmental
agents have been consistently linked to
myeloma. None of the other hemato-
logical sites was associated with an el-
evated SIR among rescue/recovery
workers. Reduced risk of later period
lung cancer in the participants not in-
volved in rescue/recovery was ob-
served. Lung cancer with its typically
long latency period will remain a con-
cern given WTC exposure to asbestos,
silica, and other carcinogens.33
This study has important strengths.
It is the first WTC cancer incidence
study that includes both sexes, all ages
and races, and both rescue/recovery
Table 5. Cox Proportional Hazard Models to Assess Risk of Cancer as a Function of World Trade Center Exposure Level by Rescue/Recovery
Work Status During the Entire Follow-up Period (2003-2008)a
Rescue/Recovery Workers
(n = 21 371)b
Participants Not Involved in Rescue or Recovery
















Low exposure level 2 6873 1 [Reference] 24 76 259 1 [Reference]
Intermediate exposure level 22 76 867 1.4 (0.3-6.5) 41 67 423 1.2 (0.7-2.0)
High exposure level 2 13 395 1.0 (0.1-7.8) 3 11 848 0.6 (0.2-2.1)
Prostate
Low exposure level 8 3582 1 [Reference] 62 35 460 1 [Reference]
Intermediate exposure level 88 62 576 0.8 (0.4-1.7) 57 28 464 0.9 (0.6-1.4)
High exposure level 14 12 349 0.8 (0.3-1.9) 10 4567 1.1 (0.6-2.2)
Thyroid
Low exposure level 2 6873 1 [Reference] 19 76 259 1 [Reference]
Intermediate exposure level 17 76 867 0.7 (0.1-3.0) 10 67 423 0.5 (0.2-1.2)
High exposure level 7 13 395 1.3 (0.3-7.0) 2 11 848 0.6 (0.1-2.7)
Non-Hodgkin lymphoma
Low exposure level 0 6873 NA 13 76 259 1 [Reference]
Intermediate exposure level 20 76 867 1 [Reference] 18 67 423 1.2 (0.6-2.4)
High exposure level 3 13 395 0.8 (0.2-2.8) 3 11 848 1.2 (0.3-4.4)
Hematological cancerd
Low exposure level 1 6873 1 [Reference] 38 76 259 1 [Reference]
Intermediate exposure level 41 76 867 3.7 (0.5-27.6) 30 67 423 0.8 (0.5-1.3)
High exposure level 9 13 395 4.5 (0.5-37.4) 3 11 848 0.4 (0.1-1.5)
Abbreviations: HR, hazard ratio; NA, not applicable.
aExposure level definitions appear in the eTable at http://www.jama.com.
bExcludes workers who worked exclusively on Staten Island site.
cAdjusted for age at enrollment, race/ethnicity, sex, income in 2002, education, source of enrollment, smoking status, and preexisting medical conditions at enrollment.
d Included leukemia, Hodgkin and non-Hodgkin lymphomas, and multiple myeloma.
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workers and those not involved in res-
cue/recovery. In addition, we con-
structed a multilevel metric of WTC ex-
posure to examine dose-response
relationships. The analysis considered
latency to the development of cancer
by dividing the follow-up into early and
later periods.
There are also important limita-
tions. First, WTC exposures were self-
reported 2 to 3 years after the Septem-
ber 11 attacks, and thus are subject to
recall error. However, numerous reg-
istry studies have established strong as-
sociations between reported levels of ex-
posures and specific health outcomes
that display a high degree of internal
consistency.2,12 Second, the cancer cases
identified through linkages with state
cancer registries might be underesti-
mated, especially among those with-
out a social security number because
about 23% of enrollees did not pro-
vide one. However, the percentage of
enrollees having a full or partial social
security number among cancer cases
was similar to that in noncases. Third,
because 70% of registry enrollees were
self-identified,13 there may be self-
selection bias.34 We attempted to miti-
gate this bias by restricting the analy-
ses to individuals without prior invasive
cancer history documented in any of the
11 state cancer registries and focusing
on cancer incidence in the later pe-
riod. Fourth, multiple comparisons (23
cancers for 2 periods) could produce
statistically significant findings that are
in fact due to chance. Fifth, the rela-
tively small number of persons with
cancer in both the low- and high-
exposure categories, and the rela-
tively short follow-up period limited our
ability to detect excess cancer risk and
the association with intensity of WTC
exposure, particularly for rarer can-
cers. Future in-depth studies of rarer
cancers may benefit from combining
data across the September 11 survivor
and/or responder cohorts to increase
sample size. In addition, we lacked in-
formation on cancer risk factors, eg,
family cancer history, occupational ex-
posures before or after September 11,
history of exposure to other environ-
mental carcinogens, and medical
screening history, especially for pros-
tate cancer.
CONCLUSION
In summary, this study found signifi-
cantly increased prostate and thyroid
cancers and mult iple myeloma
among rescue/recovery workers in
the later period that were not signifi-
cantly associated with intensity of
WTC exposures. Given the relatively
short follow-up time and lack of data
on medical screening and other risk
factors, the increase in prostate and
thyro id cance r s and mul t ip l e
myeloma should be interpreted with
caution. The etiological role of WTC
exposures in these 3 cancers is
unclear. Longer follow-up of rescue/
recovery workers and participants
not involved in rescue/recovery is
needed with attention to selected
cancer sites and to examine risk for
cancers with typically long latency
periods.
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